Carella, A M <br/><br/>
Questioning the aim of CML therapy in the era of Imatinib?  [electronic resource] 

 -  Leukemia  Jun 2003 
 - 1199-200 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2402954  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Benzamides<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Neoplasm, Residual<br/>Piperazines--therapeutic use<br/>Pyrimidines--therapeutic use